Northwestern Mutual Wealth Management CO Aclaris Therapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $121 Billion
- Q1 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 500 shares of ACRS stock, worth $775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$775
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
111Shares Held
92.4MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$22.1 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$14.9 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$13.8 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.82 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.7 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $103M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...